Literature DB >> 19750169

Pharmacological management of sickle cell disease.

Uche Anadu Ndefo, Angie Eaton Maxwell, Huong Nguyen, Tochukwu L Chiobi.   

Abstract

Year:  2008        PMID: 19750169      PMCID: PMC2730092     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


× No keyword cloud information.
  39 in total

Review 1.  Pathogenesis and treatment of sickle cell disease.

Authors:  H F Bunn
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

2.  Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension.

Authors:  Roberto F Machado; Sabrina Martyr; Gregory J Kato; Robyn J Barst; Anastasia Anthi; Michael R Robinson; Lori Hunter; Wynona Coles; James Nichols; Christian Hunter; Vandana Sachdev; Oswaldo Castro; Mark T Gladwin
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

3.  Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department.

Authors:  E R Gonzalez; N Bahal; L A Hansen; D Ware; D S Bull; J P Ornato; M E Lehman
Journal:  Arch Intern Med       Date:  1991-07

4.  Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

Authors:  T R Kinney; R W Helms; E E O'Branski; K Ohene-Frempong; W Wang; C Daeschner; E Vichinsky; R Redding-Lallinger; B Gee; O S Platt; R E Ware
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

5.  Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.

Authors:  Robert J Adams; Donald Brambilla
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

Review 6.  Treatment of sickle cell pain.

Authors:  Karen F Marlowe; Michael F Chicella
Journal:  Pharmacotherapy       Date:  2002-04       Impact factor: 4.705

7.  Discontinuing penicillin prophylaxis in children with sickle cell anemia. Prophylactic Penicillin Study II.

Authors:  J M Falletta; G M Woods; J I Verter; G R Buchanan; C H Pegelow; R V Iyer; S T Miller; C T Holbrook; T R Kinney; E Vichinsky
Journal:  J Pediatr       Date:  1995-11       Impact factor: 4.406

8.  Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial.

Authors:  A Ferster; C Vermylen; G Cornu; M Buyse; F Corazza; C Devalck; P Fondu; M Toppet; E Sariban
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

9.  Priapism associated with the sickle cell hemoglobinopathies: prevalence, natural history and sequelae.

Authors:  J E Fowler; M Koshy; M Strub; S K Chinn
Journal:  J Urol       Date:  1991-01       Impact factor: 7.450

10.  Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia.

Authors:  Sherri A Zimmerman; William H Schultz; Shelly Burgett; Nicole A Mortier; Russell E Ware
Journal:  Blood       Date:  2007-04-11       Impact factor: 22.113

View more
  9 in total

Review 1.  Folate supplementation in people with sickle cell disease.

Authors:  Ruchita Dixit; Sowmya Nettem; Simerjit S Madan; Htoo Htoo Kyaw Soe; Adinegara B L Abas; Leah D Vance; Patrick J Stover
Journal:  Cochrane Database Syst Rev       Date:  2016-02-16

2.  Relationship between disease severity and folate status of children with sickle cell anaemia in Enugu, South East Nigeria.

Authors:  Uchenna C Nnajekwu; Chukwubike O Nnajekwu; Vivian O Onukwuli; Ndubuisi A Uwaezuoke; Osita U Ezenwosu; Anthony N Ikefuna; Ifeoma J Emodi
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

3.  Pediatric Sickle Cell Disease in Sudan: Complications and Management.

Authors:  Meysaa Talha; Bashier Osman; Safa Abdalla; Hind Mirghani; Iman Abdoon
Journal:  Anemia       Date:  2022-02-14

Review 4.  Current modalities of sickle cell disease management.

Authors:  Adekunle Sanyaolu; Ejoke Agiri; Carl Bertram; Latasha Brookes; Jesy Choudhury; Dorina Datt; Amira Ibrahim; Anna Maciejko; Anna Mansfield; Jasmine Nkrumah; Martina Williams
Journal:  Blood Sci       Date:  2020-08-27

5.  Folate levels in children with sickle cell anaemia on folic acid supplementation in steady state and crises at a tertiary hospital in Enugu, Nigeria: a prospective, comparative study.

Authors:  Uchenna C Nnajekwu; Chukwubike O Nnajekwu; Vivian O Onukwuli; Bartholomew F Chukwu; Anthony N Ikefuna; Ifeoma J Emodi
Journal:  Malawi Med J       Date:  2022-06       Impact factor: 1.413

6.  Traditional herbal management of sickle cell anemia: lessons from Nigeria.

Authors:  Sunday J Ameh; Florence D Tarfa; Benjamin U Ebeshi
Journal:  Anemia       Date:  2012-11-08

Review 7.  Folate supplementation in people with sickle cell disease.

Authors:  Ruchita Dixit; Sowmya Nettem; Simerjit S Madan; Htoo Htoo Kyaw Soe; Adinegara Bl Abas; Leah D Vance; Patrick J Stover
Journal:  Cochrane Database Syst Rev       Date:  2018-03-16

8.  Prevalence of Sickle Cell Trait in the Southern Suburb of Beirut, Lebanon.

Authors:  Abdel Badih El Ariss; Mohamad Younes; Jad Matar; Zeina Berjaoui
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-02-20       Impact factor: 2.576

Review 9.  Disease burden and the role of pharmacogenomics in African populations.

Authors:  K L Mpye; A Matimba; K Dzobo; S Chirikure; A Wonkam; C Dandara
Journal:  Glob Health Epidemiol Genom       Date:  2017-02-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.